Follow us on:
  • Home
  • About Us
    • Board of Directors
    • SSCN Advisory Board
    • Our Aims And Successes
    • Freedom of Information
    • Projects
      • Stemming Expectations with Knowledge
      • Stem Cell Road Show
      • Project Realise
      • Progress to Therapy
      • Talking Stem Cells
    • Our Partners
      • Scottish Enterprise
      • Cambridge Bioscience
      • Deliverics Ltd
      • DLA Piper
      • European Regional Development Fund
      • Marks & Clerk
      • PerkinElmer
      • Sistemic
      • Vyvo BioSolutions
    • Sectors
      • Academic Research
      • Clinical Development
      • For Patients
      • Investor Community
      • Commercialisation
      • Regulatory Landscape
  • Stem Cells
    • For Patients
      • Multiple Sclerosis
      • Diabetes
      • Parkinson’s
      • Sight Loss
      • Liver Disease
      • Cardiovascular Disease
      • Blood Cancer
      • Solid Cancer Tumours
    • Glossary
  • News
    • Events
      • Upcoming Events
      • Past Events
      • SSCN Events
    • Contact
      • Contact Form
    • Capability
    • Downloads
      • Member Login
      • Sign Up For Membership

      Downloads

      • Technology and Markets
        • Scottish Enterprise Market Updates (15)
        • LiSAB (1)
      • SSCN
        • Newsletters (7)
        • SSCN Publications (4)
        • Reports (2)
        • Scotland Week 2011 (14)
        • Board Meetings Minutes (2)
      • Regulatory
        • UK (3)
        • European (3)
        • FDA (0)
        • EU IP Group (0)
      • Scottish Resources
        • Edinburgh BioQuarter (4)
        • Life Sciences Scotland (1)
        • Scottish Development International (1)
      • Miscellaneous
        • Charity Literature (1)
        • boncommence newsletter (1)
        • Industry Press Releases (1)

      Results

      Download Tags

      • update
      • brochure
      • regulatory
      • Multiple Sclerosis
      • icscn
      • technology
      • Owen Sansom
      • commercialisation
      • medical devices
      • Stem Cells
      • HFEA
      • Edinburgh
      • bioinformatics
      • newsletter
      • ATMP
      • Bruno Péault
      • Scottish Enterprise
      • Research
      • market
      • SE
      • SSCN
      • regulation
      • antoxis
      • HTA
      • EMA
      • science
      • UK Stem Cell Bank
      • project realise
      • therapy
      • cellular
      European Regional Development FundsScottish Enterprise
      Web design by Web Wise Business
      Scottish Stem Cell Network
      Wallace Building
      Roslin Biocentre
      EH25 9PP

      Tel: +44 (0) 131 440 6795 | Fax: +44 (0) 131 200 6329

      © SSCN. All rights reserved | Terms & Conditions | Privacy Policy